191 related articles for article (PubMed ID: 17060515)
1. Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
Abgueguen P; Azoulay-Dupuis E; Noel V; Moine P; Rieux V; Fantin B; Bedos JP
Antimicrob Agents Chemother; 2007 Jan; 51(1):208-14. PubMed ID: 17060515
[TBL] [Abstract][Full Text] [Related]
2. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
[TBL] [Abstract][Full Text] [Related]
3. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.
Lister PD; Pong A; Chartrand SA; Sanders CC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1926-32. PubMed ID: 9303386
[TBL] [Abstract][Full Text] [Related]
4. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
[TBL] [Abstract][Full Text] [Related]
5. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus pneumoniae pneumonia in mice: optimal amoxicillin dosing predicted from a pharmacokinetic-pharmacodynamic model.
Moine P; Mazoit JX
J Pharmacol Exp Ther; 1999 Dec; 291(3):1086-92. PubMed ID: 10565828
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
Woodnutt G; Berry V
Antimicrob Agents Chemother; 1999 Jan; 43(1):35-40. PubMed ID: 9869562
[TBL] [Abstract][Full Text] [Related]
8. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.
Moine P; Mazoit JX; Bédos JP; Vallée E; Azoulay-Dupuis E
J Pharmacol Exp Ther; 1997 Jan; 280(1):310-5. PubMed ID: 8996211
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla.
Alper CM; Doyle WJ; Seroky JT; Bluestone CD
Antimicrob Agents Chemother; 1996 Aug; 40(8):1889-92. PubMed ID: 8843299
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
11. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
[TBL] [Abstract][Full Text] [Related]
13. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
Andes D; Craig WA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2375-9. PubMed ID: 9736566
[TBL] [Abstract][Full Text] [Related]
14. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae.
Barry B; Muffat-Joly M; Gehanno P; Pocidalo JJ
Antimicrob Agents Chemother; 1993 Aug; 37(8):1599-603. PubMed ID: 8215269
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
[TBL] [Abstract][Full Text] [Related]
16. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.
Gisby J; Wightman BJ; Beale AS
Antimicrob Agents Chemother; 1991 May; 35(5):831-6. PubMed ID: 1854164
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
Gracia M; Martínez-Marín C; Huelves L; Giménez MJ; Aguilar L; Carcas A; Ponte C; Soriano F
Antimicrob Agents Chemother; 2005 Mar; 49(3):996-1001. PubMed ID: 15728894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
